友邦保險(1299.HK)高開2.96% 領漲恆指
格隆匯11月4日丨友邦保險(1299.HK)跳空高開2.96%,開報81.85港元,盤前成交2.91億港元,最新總市值9895億港元。友邦高開帶動恆指上漲76.88點。公司10月28日公佈的財報顯示,第三季,新業務價值上升1%至9.80億美元;不計入香港業務,新業務價值增長14%;年化新保費減少8%至14.44億美元;新業務價值利潤率增加6.0個百分點至67.0%;總加權保費收入上升8%至81.68億美元。公告稱,整體而言,年化新保費較2018年第三季減少8%至14.44億美元。業績公佈後,中金重申友邦“跑贏行業”評級,維持目標價101港元。小摩對其維持增持評級,目標價雖由100港元下調至99港元,但也明顯高於現價。花旗予友邦“買入”評級,目標價90港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.